Moderna Provides Update on Norovirus Vaccine Candidate
1 day ago · Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. It is currently being evaluated in the randomized, observer-blinded, placebo-controlled phase 3 Nova 301 trial (ClinicalTrials.gov Identifier: NCT06592794 ) for the prevention of moderate or severe acute ...
Sick of the stomach bug? Moderna is making a norovirus vaccine
1 day ago · Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.
A norovirus vaccine could be on the horizon as cases rise
2 days ago · Moderna is testing a norovirus vaccine in a phase three trial, with results available as soon as this year. Norovirus cases are on the rise this winter, with outbreaks already up more than 30% by ...
A genetic quirk protects some people from norovirus. Can vaccines ... - BBC
Dec 31, 2024 · Researchers at the University of North Carolina believe that if a suitably broad norovirus vaccine is administered to children who are around six months old, the jab could then guide the...
A Norovirus Vaccine Is in the Works | TIME
Jan 10, 2025 · There is no antiviral treatment for the miserable but thankfully short-lived illness, and no vaccine—yet. But scientists at Moderna are in the late stages of testing what could be the first such...
Moderna says it’s ‘one step closer’ to a norovirus vaccine as the …
Jan 13, 2025 · Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403. “Stomach bug,” “cruise-ship virus,” “winter...
From Covid to Norovirus: Moderna’s mRNA Tech Takes on
5 days ago · The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent ...
News Details
Sep 30, 2024 · mRNA-1403 is an mRNA vaccine in development to prevent moderate to severe acute gastroenteritis caused by norovirus. The vaccine candidate is a trivalent formulation containing mRNA that encodes for virus-like particles (VLPs) designed to protect against multiple norovirus genotypes.
Norovirus: Vaccine to be trialled for vomiting bug - BBC
Oct 22, 2024 · A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea.
Norovirus: Trial call-out to test winter stomach bug vaccine - BBC News
Nov 6, 2024 · People over the age of 60 are being invited to test a vaccine that aims to protect them from norovirus. The virus, a stomach bug that causes vomiting and diarrhoea, is easily spreadable during...